Table 2.
Treatment-related AEs
| Grade 1/2 | Grade 3/4 | |
|---|---|---|
| Leukopenia | 12 (55%) | 2 (9%) |
| Neutropenia | 7 (32%) | 7 (32%) |
| Anemia | 14 (64%) | 1 (5%) |
| Thrombocytopenia | 2 (9%) | 1 (5%) |
| Hypofibrinogenemia | 12 (55%) | 4 (18%) |
| Prolonged activated partial thromboplastin time | 10 (45%) | 0 |
| Hypoalbuminemia | 15 (68%) | 1 (5%) |
| Hyperbilirubinemia | 16 (73%) | 0 |
| ALT elevation | 9 (41%) | 1 (5%) |
| AST elevation | 11 (50%) | 1 (5%) |
| Creatine | 3 (14%) | 0 |
| Hyponatremia | 11 (50%) | 0 |
| Hyperkalemia | 7 (32%) | 0 |
| Serum amylase increased | 3 (14%) | 0 |
| Hyperglycemia | 3 (14%) | 0 |
| Hypertriglyceridemia | 4 (18%) | 1 (5%) |
| Hypothyroidism | 8 (36%) | 0 |
| Nausea | 5 (23%) | 0 |
| Vomiting | 1 (5%) | 0 |
| Diarrhea | 0 | 0 |
| Mucositis | 5 (23%) | 0 |
| Infection | 0 | 0 |
| Heart failure | 0 | 1 (5%) |